Liver is a target of arsenic carcinogenesis
- PMID: 18566022
- PMCID: PMC2734307
- DOI: 10.1093/toxsci/kfn120
Liver is a target of arsenic carcinogenesis
Abstract
Inorganic arsenic is clearly a human carcinogen causing tumors of the skin, lung, urinary bladder, and possibly liver (IARC, 2004). At the time of construction of this monograph, the evidence for arsenic as a hepatocarcinogen in humans was considered controversial and in rodents considered insufficient. However, recent data has accumulated indicating hepatocarcinogenicity of arsenic. This forum reevaluates epidemiology studies, rodent studies together with in vitro models, and focuses on the liver as a target organ of arsenic toxicity and carcinogenesis. Hepatocellular carcinoma and hepatic angiosarcoma, have been frequently associated with environmental or medicinal exposure to arsenicals. Preneoplastic lesions, including hepatomegaly, hepatoportal sclerosis, fibrosis, and cirrhosis often occur after chronic arsenic exposure. Recent work in mice clearly shows that exposure to inorganic arsenic during gestation induces tumors, including hepatocellular adenoma and carcinoma, in offspring when they reach adulthood. In rats, the methylated arsenicals, dimethylarsinic acid promotes diethylnitrosamine-initiated liver tumors, whereas trimethylarsine oxide induces liver adenomas. Chronic exposure of rat liver epithelial cells to low concentrations of inorganic arsenic induces malignant transformation, producing aggressive, undifferentiated epithelial tumors when inoculated into the Nude mice. There are a variety of potential mechanisms for arsenical-induced hepatocarcinogenesis, such as oxidative DNA damage, impaired DNA damage repair, acquired apoptotic tolerance, hyperproliferation, altered DNA methylation, and aberrant estrogen signaling. Some of these mechanisms may be liver specific/selective. Overall, accumulating evidence clearly indicates that the liver could be an important target of arsenic carcinogenesis.
Similar articles
-
Transplacental arsenic carcinogenesis in mice.Toxicol Appl Pharmacol. 2007 Aug 1;222(3):271-80. doi: 10.1016/j.taap.2006.12.034. Epub 2007 Jan 12. Toxicol Appl Pharmacol. 2007. PMID: 17306315 Free PMC article.
-
Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen.Toxicol Appl Pharmacol. 2006 Sep 15;215(3):295-305. doi: 10.1016/j.taap.2006.03.010. Epub 2006 May 18. Toxicol Appl Pharmacol. 2006. PMID: 16712894
-
Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.Toxicol Appl Pharmacol. 2001 May 1;172(3):249-61. doi: 10.1006/taap.2001.9157. Toxicol Appl Pharmacol. 2001. PMID: 11312654 Review.
-
Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice.Arch Toxicol. 2012 Jun;86(6):975-82. doi: 10.1007/s00204-012-0820-8. Epub 2012 Mar 8. Arch Toxicol. 2012. PMID: 22398986 Free PMC article.
-
[Exploration of Epigenetic Changes and DNA Methylation Markers Associated with Liver Tumors Induced by Inorganic Arsenite Exposure in Mice].Nihon Eiseigaku Zasshi. 2015;70(3):181-5. doi: 10.1265/jjh.70.181. Nihon Eiseigaku Zasshi. 2015. PMID: 26411935 Review. Japanese.
Cited by
-
Resveratrol Alleviates Arsenic Exposure-Induced Liver Fibrosis in Rats by Inhibiting Hepatocyte Senescence.Biol Trace Elem Res. 2024 Jun 3. doi: 10.1007/s12011-024-04255-9. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38831176
-
Chronic Exposure to Arsenic and Fluoride Starting at Gestation Alters Liver Mitochondrial Protein Expression and Induces Early Onset of Liver Fibrosis in Male Mouse Offspring.Biol Trace Elem Res. 2024 Apr 27. doi: 10.1007/s12011-024-04198-1. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38676876
-
Micro-distribution of arsenic in toenail clippings using laser ablation inductively coupled plasma mass spectrometry: implications for biomonitoring.Environ Monit Assess. 2024 Jan 21;196(2):181. doi: 10.1007/s10661-024-12360-4. Environ Monit Assess. 2024. PMID: 38246977
-
Update of the risk assessment of inorganic arsenic in food.EFSA J. 2024 Jan 18;22(1):e8488. doi: 10.2903/j.efsa.2024.8488. eCollection 2024 Jan. EFSA J. 2024. PMID: 38239496 Free PMC article.
-
Hormetic effects of curcumin on oxidative stress injury induced by trivalent arsenic in isolated rat hepatocytes.Avicenna J Phytomed. 2023 Nov-Dec;13(6):641-650. doi: 10.22038/AJP.2023.22634. Avicenna J Phytomed. 2023. PMID: 38106636 Free PMC article.
References
-
- Buchet JP, Geubel A, Pauwels S, Mahieu P, Lauwerys R. The influence of liver disease on the methylation of arsenite in humans. Arch. Toxicol. 1984;55:151–154. - PubMed
-
- Chen CJ, Chuang YC, Lin TM, Wu HY. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers. Cancer Res. 1985;45:5895–5899. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical